Home » Stocks » ONVO » Company

Organovo Holdings, Inc. (ONVO)

Stock Price: $8.58 USD 0.41 (5.02%)
Updated Jun 22, 2021 4:00 PM EDT - Market closed
Organovo Holdings, Inc.
Founded 2007
Industry Diagnostics & Research
Sector Healthcare

Contact Details

Address:440 Stevens Avenue
Solana Beach, CA 92075
United States
Phone 858 224 1000

Stock Information

Ticker Symbol ONVO
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency US Dollars
CIK Code 0001497253
CUSIP Number 62620A104
ISIN Number US68620A2033
Employer ID 27-1488943

Company Description

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.

Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.

The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases.

The company was incorporated in 2007 and is headquartered in Solana Beach, California.

Key Executives

NamePosition
Keith E. MurphyExecutive Chairman and Principal Executive Officer
Jonathan I. LieberPresident and Chief Financial Officer
Dr. Jeffrey N. MinerChief Scientific Officer
Steve E. KunszaboVice President of Investor Relations and Corporate Communications
Thomas Einar JurgensenGeneral Counsel and Corporate Secretary